Latest Announcements

BSE & NSE corporate filings with AI summaries

BSECompany UpdateResults12 Aug 2026

Pasupati Fincap Ltd

Newspaper Publication for Financial Results.

Pasupati Fincap Ltd has published its unaudited financial results for the quarter ended June 30, 2026, in accordance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were approved by the Board of Directors on August 11, 2026, and have been published in the Financial Express and Jansatta newspapers on August 12, 2026.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults12 Aug 2026

Marksans Pharma Limited

Press Release

Marksans Pharma reported Q1FY27 financial results with record profitability, with EBITDA rising 113% YoY to ₹213 crore and PAT growing 174% YoY to ₹159 crore. The company also achieved its highest-ever quarterly revenue of ₹841 crore and crossed ₹1,000 crore in cash balance for the first time.

Read more →📎 1 attachment
NSECopy of Newspaper Publication12 Aug 2026

Global Health Limited

Copy of Newspaper Publication

Global Health Limited has informed the Exchange about Copy of Newspaper Publication regarding the 22nd Annual General Meeting of the Company scheduled to be held on September 16, 2026, and an e-tender notice for the procurement of distribution transformers.

Read more →📎 1 attachment
BSEBoard MeetingResults12 Aug 2026

Valiant Communications Ltd-$

As attached

Valiant Communications Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at ₹2,514 lakhs and profit before tax at ₹1,080 lakhs.

Read more →📎 1 attachment
BSECompany UpdateMgmt Change12 Aug 2026

Vidya Wires Ltd

Enclosed herewith attached Intimation under Regulation 30(5) for updated list of key managerial personnel authorized to determine materiality of an event or information

Vidya Wires Ltd has updated the list of Key Managerial Personnel authorized to determine materiality of an event or information and to make disclosures to the Stock Exchanges, as per Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults12 Aug 2026

Marksans Pharma Ltd

Press Release for Financial Results Q1 FY 27

Marksans Pharma Ltd reported Q1FY27 financial results, with record profitability and cash balance crossing ₹1,000 crore. EBITDA rose 113% YoY to ₹213 crore, and PAT grew 174% YoY to ₹159 crore. The company's UK & Europe business delivered its highest-ever quarterly revenue of ₹356 crore, growing 74.7% YoY.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults12 Aug 2026

Marksans Pharma Ltd

Investor Presentation Q1 FY 27

Marksans Pharma Ltd has announced its Q1 FY 27 financial results, with revenue growing 35.6% YoY to ₹841 cr, EBITDA increasing 112.8% to ₹213 cr, and PAT rising 173.9% to ₹159.4 cr. The company has also reported an all-time high quarterly EBITDA of ₹213 crore and PAT of ₹159 crore. The UK & Europe segment delivered its highest-ever quarterly revenue of ₹356 crore, growing 74.7% YoY.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults12 Aug 2026

Marksans Pharma Limited

Investor Presentation

Marksans Pharma Limited has released its Q1FY27 investor presentation, highlighting a strong start to the year with all-time high quarterly EBITDA of ₹213 crore and PAT of ₹159 crore.

Read more →📎 1 attachment
← PreviousPage 1198 of 4341Next →